Agriculture

Our Stories

We have reached remarkable achievements in the fight against mosquito-borne diseases such as malaria, dengue, chikungunya, West Nile Virus and yellow fever. Controlling the mosquitoes and insects that spread these illnesses is a critical investment in the future can result in fewer sick people, better school attendance, stronger economies and a healthier, brighter future for entire communities. Read our stories to learn how we collaborate with partners to improve the quality of life for people around the globe through disease prevention.

Results: 21

Creating a circular economy

The management of insecticide-treated nets (ITNs) waste is a high priority in environmental management. Considering that over three billion ITNs have been shipped to malaria-endemic countries since 2004, it is certain that large quantities of plastic materials from these nets remain in the environment, particularly in sub-Saharan Africa.

Flood Relief Pakistan

BASF donates vector-borne disease control tools for Pakistan.

35 million nets to boost the fight against malaria

Eliminating malaria remains one of humanity’s most serious challenges. Children under the age of five and pregnant women are particularly at risk. However, malaria is curable and, most importantly, preventable.
Young Girls Pumping Water At A Public Borehole in West Africa

No flight – no bite

In our efforts to combat the spread of malaria, our researchers have created the Interceptor® G2 bed net that makes mosquitoes unable to fly or move and thereby reduces infection rates among children by up 60%., according to new research published in The Lancet.

Mosquitoes and bed bugs – unfortunate bedfellows in the fight against malaria

We have made much progress over the past two decades in tackling malaria. But another pest that has made its home close to humans – the bed bug – is complicating efforts. We look at how the two issues are connected and ask whether nets that use an insecticide that is effective on both mosquitoes and bed bugs, like BASF’s Interceptor® G2, could be part of the solution.